TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 South & Central America Embolotherapy Market – by Product
1.3.2 South & Central America Embolotherapy Market – by Disease Indication
1.3.3 South & Central America Embolotherapy Market – by Procedure
1.3.4 South & Central America Embolotherapy Market – by End User
1.3.5 South & Central America Embolotherapy Market– By Country
2. South & Central America Embolotherapy Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Embolotherapy Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Expert Opinion
5. South & Central America Embolotherapy Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Burgeoning Incidence of Cancer Cases
5.1.2 Broadening Patient Preference for Minimally Invasive Procedures
5.2 Market Restraints
5.2.1 Access of Other Alternative Therapies
5.3 Market Opportunity
5.3.1 Elevating Applications of Embolotherapy
5.4 Market Trend
5.4.1 Widening Use of Liquid Embolic Agents
5.5 Impact analysis
6. South & Central America Embolotherapy Market Analysis
6.1 South & Central America Embolotherapy Market Revenue Forecast and Analysis
7. South & Central America Embolotherapy Market – by Product
7.1 Overview
7.2 South & Central America Embolotherapy Market Revenue Share, by Products 2022 & 2028 (%)
7.3 Embolic Agents
7.3.1 Overview
7.3.2 Embolic Agents: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
7.3.3 Microspheres
7.3.3.1 Overview
7.3.3.2 Microspheres: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
7.3.4 Embolic Coils
7.3.4.1 Overview
7.3.4.2 Embolic Coils: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
7.3.5 Embolic Plug Systems
7.3.5.1 Overview
7.3.5.2 Embolic Plug Systems: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
7.3.6 Detachable Balloons
7.3.6.1 Overview
7.3.6.2 Detachable Balloons: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
7.3.7 Liquid Embolic Agents
7.3.7.1 Overview
7.3.7.2 Liquid Embolic: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
7.3.8 Others
7.3.8.1 Overview
7.3.8.2 Others: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
7.4 Support Devices
7.4.1 Overview
7.4.2 Support Devices: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
7.4.3 Microcatheters
7.4.3.1 Overview
7.4.3.2 Microcatheters: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
7.4.4 Guidewires
7.4.4.1 Overview
7.4.4.2 Guidewires: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
8. South & Central America Embolotherapy Market Analysis – by Disease Indication
8.1 Overview
8.2 South & Central America Embolotherapy Market Revenue Share, by Disease Indication 2022 & 2028 (%)
8.3 Cancer
8.3.1 Overview
8.3.2 Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
8.3.2.1 Liver Cancer
8.3.2.1.1 Overview
8.3.2.1.2 Liver Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
8.3.2.2 Kidney Cancer
8.3.2.2.1 Overview
8.3.2.2.2 Kidney Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
8.3.2.3 Other Cancers
8.3.2.3.1 Overview
8.3.2.3.2 Other Cancers: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Peripheral Vascular Diseases
8.4.1 Overview
8.4.2 Peripheral Vascular Diseases: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Neurological Diseases
8.5.1 Overview
8.5.2 Neurological Diseases: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Urological and Nephrological Disorders
8.6.1 Overview
8.6.2 Urological and Nephrological Disorders: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Gastrointestinal Disorders
8.7.1 Overview
8.7.2 Gastrointestinal Disorders: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
9. South & Central America Embolotherapy Market Analysis – by Procedure
9.1 Overview
9.2 South & Central America Embolotherapy Market Revenue Share, by Procedure 2022 & 2028 (%)
9.3 Transcatheter Arterial Embolization (TAE)
9.3.1 Overview
9.3.2 Transcatheter Arterial Embolization (TAE): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT)
9.4.1 Overview
9.4.2 Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Transarterial Chemoembolization (TACE)
9.5.1 Overview
9.5.2 Transarterial Chemoembolization (TACE): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
10. South & Central America Embolotherapy Market Analysis – By End User
10.1 Overview
10.2 South & Central America Embolotherapy Market Revenue Share, By End User 2022 & 2028 (%)
10.3 Hospitals and Clinics
10.3.1 Overview
10.3.2 Hospitals: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
10.4 Ambulatory Surgical Centers
10.4.1 Overview
10.4.2 Ambulatory Surgical Centers: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
10.5 Other End Users
10.5.1 Overview
10.5.2 Other End Users: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
11. South & Central America Embolotherapy Market – Country Analysis
11.1 Overview
11.1.1 South & Central America: Embolotherapy Market, by Country, 2022 & 2028 (%)
11.1.1.1 Brazil: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.1 Brazil: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.2 Brazil Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.2.1 Brazil Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.2.2 Brazil Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.3 Brazil Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.3.1 Brazil Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.4 Brazil Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.5 Brazil Embolotherapy Market, by End User– Revenue and Forecast to 2028 (US$ Million)
11.1.1.2 Argentina: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.1 Argentina: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.2 Argentina Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.2.1 Argentina Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.2.2 Argentina Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.3 Argentina Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.3.1 Argentina Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.4 Argentina Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.5 Argentina Embolotherapy Market, by End User– Revenue and Forecast to 2028 (US$ Million)
11.1.1.3 Rest of South and Central America: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.1 Rest of SAM: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.2 Rest of SAM Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.2.1 Rest of SAM Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.2.2 Rest of SAM Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.3 Rest of SAM Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.3.1 Rest of SAM Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.4 Rest of SAM Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.5 Rest of SAM Embolotherapy Market, by End User– Revenue and Forecast to 2028 (US$ Million)
12. South & Central America Embolotherapy Market –Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 Abbott Laboratories
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Boston Scientific Corporation
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Cook Medical LLC
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Johnson & Johnson
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Medtronic
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Acandis GmbH
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Balt USA LLC
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Stryker Corporation
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Guerbet LLC
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Terumo Corporation
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES.
Table 1. Brazil Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 2. Brazil Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
Table 3. Brazil Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)
Table 4. Brazil Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 5. Brazil Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)
Table 6. Brazil Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
Table 7. Brazil Embolotherapy Market, by End User– Revenue and Forecast to 2028 (US$ Million)
Table 8. Argentina Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 9. Argentina Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
Table 10. Argentina Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)
Table 11. Argentina Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 12. Argentina Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)
Table 13. Argentina Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
Table 14. Argentina Embolotherapy Market, by End User– Revenue and Forecast to 2028 (US$ Million)
Table 15. Rest of SAM Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 16. Rest of SAM Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
Table 17. Rest of SAM Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)
Table 18. Rest of SAM Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 19. Rest of SAM Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)
Table 20. Rest of SAM Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
Table 21. Rest of SAM Embolotherapy Market, by End User– Revenue and Forecast to 2028 (US$ Million)
Table 22. Organic Developments Done by Companies
Table 23. Inorganic Developments Done by Companies
Table 24. Glossary of Terms, South & Central America Embolotherapy Market